acute lymphoblastic leukaemia

Showing 4 posts of 4 posts found.

Sanofi acquires biotech firm Synthorx for $2.5 billion

December 9, 2019
Sales and Marketing Genetic Alphabet, Sanofi, acute lymphoblastic leukaemia, leukaemia

Sanofi has agreed to buy California-based biotechnology firm Synthrox, in a deal worth about $2.5 billion (£1.95 billion). Paul Hudson, …

NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population

June 19, 2019
Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma

Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …


Patient deaths lead Juno Therapeutics to halt trial for second time

November 24, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute lymphoblastic leukaemia, clinical trial deaths, juno therapeutics

Juno Therapeutics has been forced to halt a trial investigating the efficacy of its lead experimental CAR-T cancer treatment JCAR015 …

Pfizer’s leukaemia drug beats chemotherapy in Phase III trials

June 13, 2016
Research and Development, Sales and Marketing Inotuzumab ozogamicin, Pfizer, acute lymphoblastic leukaemia

Pfizer (NYSE: PFE) has announced data from a pivotal Phase III trial for acute lymphoblastic leukaemia (ALL) drug, inotuzumab ozogamicin, …

Latest content